Edit

Hikma Ventures

https://www.hikmaventures.com

Last activity: 10.09.2025

Active

Founded in August 2015, Hikma Ventures operates as the corporate venture capital arm of Hikma Pharmaceuticals.

Our primary focus is to identify and invest in emerging companies in the digital health space, globally, that could enhance Hikma’s value proposition, reputation and market intelligence.

We will also consider investments in other healthcare related areas of current or future strategic interest to Hikma, including drug delivery technologies that have the potential to enhance Hikma's value chain and pipeline.

HV will act as an instrument of strategic growth in broadening Hikma’s offerings; it will allow Hikma to tap into opportunities in the growing digital healthspace.

HV will invest in companies where Hikma's expertise can accelerate revenue growth and enhance value creation by providing ventures with access to the resources of a multinational pharmaceutical company.

We will invest in companies at all stages of development, including start-ups. HV looks at global opportunities.
Our initial investment size is up to $5 million per round.

We seek to actively partner with the management teams of portfolio companies to realize the potential of their products and technologies.

Hikma Ventures has invested and continues to invest in companies in the digital health space, globally, that have the potential to enhance ours value chain and pipeline.

Portfolio

Mentions

Location: United Kingdom, England, Westminster

Employees: 1-10

Founded date: 2015

Investment Type: Venture Capital

Portfolio 2

Date	Name	Website	Total Raised	Location
10.09.2025	Octave Bio...	octavebio.com	$121.6M	United Sta...
11.05.2023	Prognos He...	prognoshealth.com	$23M	United Sta...

Mentions in press and media 25

Date	Title	Description
11.09.2025	Octave Bioscience Secures Major Funding for Precision Neurology Advancement	Octave Bioscience secured $51.1 million in fresh capital. This includes a $35.6 million Series C equity round and a $15.5 million debt facility. Funds accelerate MSDA test commercialization. This blood-based diagnostic tool measures Multipl...
10.09.2025	Octave Bioscience: $35 Million Raised For Advancing Precision Care For Neurological Diseases	Octave Bioscience, a company focused on precision medicine for neurodegenerative conditions, has announced the successful close of a $35.6 million Series C equity financing round. In addition to this funding, the company has secured a $15.5...
05.09.2025	Octave Bioscience Raises $35M in Series C Financing	Octave Bioscience, a Menlo Park, CA-based commercial stage precision care company, announced the close of its $35.6M Series C equity financing and that it has entered into a $15.5M non-dilutive term loan agreement with Silicon Valley Bank (...
23.04.2025	Biolinq's $100 Million Leap: A New Era for Diabetes Management	In the world of health technology, innovation is the lifeblood. Biolinq, a California-based company, has just injected a hefty $100 million into its vision for the future of diabetes management. This Series C funding round, led by Alpha Wav...
22.04.2025	Biolinq Raises $100M to Expand Biowearable Platform for Metabolic Health	What You Should Know: – Biolinq, a healthcare technology company focused on developing precision multi-analyte biosensors to improve metabolic health raises $100M in Series C financing round led by Alpha Wave Ventures, with participation fr...
07.04.2022	Egypt’s O7 Therapy lands game-changing $2.1M in funding	Credit: O7 Therapy
01.04.2022	Additional $14 million for Altoida to advance its neurocognitive assessment platform
26.08.2020	SeamlessMD raises $4 million CAD Series A to meet increased demand for digital patient engagement due to COVID-19	Toronto healthtech startup SeamlessMD, which provides a cloud-based patient engagement app, has raised a $4 million CAD Series A round led by Montreal’s MEDTEQ+, a federally and provincially-funded Quebec non-profit that invests in medical ...
31.07.2020	Lemonaid Health Raises $33M to Expand On-Demand Consumer Telehealth Platform	What You Should Know: – Lemonaid Health, a direct to consumer telehealth company raises $33M in Series B funding to expand the company’s medical team and number of services being offered to patients. – To date, the company has treated more ...
05.05.2020	Hikma Ventures invests in Altoida
05.05.2020	Hikma Ventures invests in Altoida	The number of people living with Alzheimer's disease is rapidly growing. In 2019 alone, Alzheimer's disease and other dementias cost the US $290 billion. By 2050, these costs could rise as high as $1.1 trillion, according to the 2019 Facts ...
25.11.2019	Today in funding ($10.26 million): Winterlight Labs, Casca	Two Canadian startups have announced fresh funding rounds to fuel their growth. Here’s the latest on who raised how much, from whom, and what they’ll be putting the new funds toward. Winterlight Labs raises $5.6 million CAD in Series A fund...
29.05.2019	Pillo Health Raises $11M to Expand Personal Home Health Robot	Pillo Health, a Boston-based digital health company improving longevity and quality of life for patients managing their health at home has raised $11M in Series A funding, led by Stanley Black & Decker’s corporate venture capital arm wi...
14.01.2019	Breakdown of biggest VC raises in Midwestern states in 2018	As the new year gets underway, 2018’s fundraising numbers are rolling in, allowing us to get a snapshot of how the Midwest’s top startups fared. It was a good year for the Midwest, which we define here as Minnesota, Wisconsin, Illinois, Ind...
11.01.2019	Breakdown of biggest VC raises in Midwestern states in 2018	We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today! As the new year gets underway, 2018’s fundraising...
11.01.2019	Breakdown of biggest VC raises in Midwestern states in 2018	As the new year gets underway, 2018’s fundraising numbers are rolling in, allowing us to get a snapshot of how the Midwest’s top startups fared. It was a good year for the Midwest, which we define here as Minnesota, Wisconsin, Illinois, Ind...
30.05.2018	As Propeller Health closes latest fundraise, it expands digital drug delivery ambitions beyond inhalers	Propeller and Aptar initially collaborated in 2016 on an integrated connected metered dose inhaler. They plan to co-market the technologies coming out of the joint venture — Propeller will manage the digital services and Aptar Pharma will m...
22.05.2017	Correlation Joins $11M Series A for Lemonaid Health	Lemonaid Health, the simplest and fastest platform for online healthcare, today announced $11 million in new funding to support continued innovation in affordable online healthcare. The Series A funding round was led by Novartis Venture Fun...
22.05.2017	NVF Leads $11M Series A for Lemonaid Health	Lemonaid Health, the simplest and fastest platform for online healthcare, today announced $11 million in new funding to support continued innovation in affordable online healthcare. The Series A funding round was led by Novartis Venture Fun...
20.10.2016	Propeller Health closes Series C round, plans to add more respiratory meds to adherence platform	SR One, the investment arm of GlaxoSmithKline, Hikma Ventures, part of Hikma Pharmaceuticals, and 3M Ventures, all new investors to Propeller Health, took part in the Series C round alongside existing investors Safeguard Scientifics and Soc...
08.09.2016	Chrono Therapeutics raises $47.6M for smoking cessation wearable to deliver nicotine fix before you wake	The wearable also has a “crave” button users can press that records the moment they want a cigarette and triggers an immediate coaching message through the app to help the user get through the moment without smoking. There is also a behavio...
-	Propeller Health closes Series C round, plans to add more respiratory meds to adherence platform	Propeller Health’s app and connected inhalers. Propeller Health, which developed a way for pharma companies and patients to quantify and contextualize asthma and COPD medication adherence, closed a $21.5 million Series C financing round, ac...
-	Chrono Therapeutics raises $47.6M for smoking cessation wearable to deliver nicotine fix before you wake	Smoking cessation is a big priority for self-insured employer programs and payers, particularly since most payers are inclined to reimburse for these programs because of the impact of smoking on health. The challenge, as Chrono Therapeutics...
-	As Propeller Health closes latest fundraise, it expands digital drug delivery ambitions beyond inhalers	Source: Propeller Health Propeller Health, which works with pharma companies to develop sensors to convert inhalers into connected devices, has closed a $20 million funding round and has inked a strategic partnership with Aptar Pharma. The ...
-	Whats’s the future of digital medicines? Find out at INVEST PharmaTech.	Digital medicine adoption, also referred to as digital therapeutics, was challenging ahead of the pandemic. Clinical validation and FDA clearances have gradually moved the needle on how these treatments are perceived. But the need for remot...

Hikma Ventures

Portfolio 2

Mentions in press and media 25

Reviews 0